Peter Clausen serves as Executive at Nuo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Peter Clausen has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 31, 2025 involved exercising options for 183,853 shares valued at $73.5K.
Peter Clausen currently holds 770,054 shares of Nuo Therapeutics, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Clausen has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Peter Clausen's most recent insider trade was on Jul 31, 2025, when they sold 183,853 shares at $0.40 per share.
Get notified when new Form 4 filings are submitted
| 15,000 |
| $0.75 |
| Discretionary |
| Dec 19, 2023 | AURX | $10.0K | Award | 20,000 | $0.50 | Discretionary |
| Aug 1, 2023 | AURX | $50.0K | Award | 25,000 | $2.00 | Discretionary |
| Apr 29, 2022 | AURX | $25.0K | Award | 25,000 | $1.00 | Discretionary |
| May 5, 2016 | NONE | $0 | Other | 1,201 | $N/A | Discretionary |
| May 5, 2016 | NONE | $0 | Other | 3,474 | $N/A | Discretionary |